TrialPath

Find a study

Browse recruiting studies near you — free to check, always your choice.

Match me to a study

358 studies

Recruiting now, in plain language. Every study is watched over by an independent ethics board.

  • Migraine / chronic headache

    BOTOX® vs. XEOMIN® for Chronic Migraine

    Comparing two injections to treat chronic migraine

    📍 Naval Medical Center Camp Lejeune · Jacksonville, NC · Get directions →

    Chronic migraine (CM) is a disabling disorder that sidelines active duty personnel and diminishes their quality of life. It affects 1.3% to 2.4% of the general population.

    ✓ Study care freePhase 3Ages 18–89Learn more →
  • COPD (chronic lung disease)

    A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

    Testing two doses of a medicine versus placebo for COPD symptoms

    📍 Research Site · Birmingham, AL · +39 more US sites · Get directions →

    This Phase IIb dose-ranging study will evaluate the efficacy and safety of 2 different doses of AZD6793 compared with placebo tablets in participants with moderate to very severe chronic obstructive pulmonary disease.

    ✓ Study care freePhase 2Ages 40+Learn more →
  • Migraine / chronic headache

    Migraine in Adolescents

    Studying what brain and behavior factors can predict migraine onset in adolescents

    📍 Washington University School of Medicine · St Louis, MO · Get directions →

    Aim 1. To identify psychophysical and neural factors predicting migraine onset in adolescents Aim 2a.

    ✓ Study care freeAges 10–13Learn more →
  • Migraine / chronic headache

    Responding With Evidence and Access for Childhood Headaches

    Testing how well headache prevention options and telehealth CBT work for youth with migraine

    📍 University of Alabama at Birmingham Children's of Alabama · Birmingham, AL · +14 more US sites · Get directions →

    This comparative effectiveness study will clarify current first-line preventive treatment approaches for use by neurologists, psychologists, and primary care providers in the context of real world care, and will demonstrate the feasibility of Cognitive Behavioral Therapy (CBT) via telehealth for youth with migraine. The focus is on applying evidence-based care and enhancing access to it.

    ✓ Study care freeAges 10–17Learn more →
  • COPD (chronic lung disease)

    Predicting Acute Exacerbations of COPD Using Wearable Devices and Remote Monitoring Technology With AI/ML Models

    Testing if wearable devices and AI can predict COPD flare-ups

    📍 McGill University Health Centre · Montreal, Quebec · Get directions →

    This study is aimed to collect real-time physiological data using two wearable devices (a biometric ring and a biometric wristband), daily lung mechanical measurements by a handheld oscillometer, and participant-reported symptoms in patients with COPD remotely from their home environment. The data will be used to train and validate artificial intelligence and machine learning (AI/ML) models to predict COPD exacerbations in advance of their actual occurrence.

    ✓ Study care freeAges 40+Learn more →
  • COPD (chronic lung disease)

    Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency

    Testing how a genetic change in alpha-1 antitrypsin affects immune and lung responses to a pneumonia

    📍 University of Alabama at Birmingham · Birmingham, AL · Get directions →

    The goal of this study is to learn whether patients who have a genetic mutation in the genes that cause alpha 1 antitrypsin deficiency also have genetic variation in nearby genes that can increase risk for reduced immune function and respiratory infections. To investigate this hypothesis, we will compare immune responses to the 20-valent pneumococcal conjugate vaccine (PCV20, Pfizer) between participants who have one abnormal copy of the SERPINA1 gene and either no COPD exacerbations, vs those with 2 or more COPD exacerbations in the past year.

    ✓ Study care freePhase 4Ages 19+Learn more →
  • Heart / cardiovascular diseaseCOPD (chronic lung disease)

    Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF

    Testing a remote mindful program to increase daily steps in people with COPD and heart failure

    📍 VA Boston · Boston, MA · +1 more US site · Get directions →

    The goal of this fully-remote randomized controlled trial is to test the efficacy of Mindful Steps in facilitating physical activity compared to usual standard of care among 136 patients with COPD and/or HF. The main question it aims to answer is can this intervention promote physical activity as measured by daily step counts in sedentary patients with COPD and/or HF.

    ✓ Study care freeAges 40+Learn more →
  • Heart / cardiovascular diseaseCOPD (chronic lung disease)

    Passive Heat Therapy for People With COPD

    Testing whether a 45-minute hot-water footbath improves blood flow in people with COPD

    📍 University of British Columbia · Kelowna, British Columbia · Get directions →

    People with Chronic Obstructive Pulmonary Disease (COPD) often develop high blood pressure and heart disease due to their sedentary lifestyle and difficulty exercising. The investigators will test if heating can mimic the health benefits of exercise by monitoring the increase in leg blood-flow using ultrasound during a 45-minute hot-water footbath.

    ✓ Study care freeAges 40+Learn more →
  • COPD (chronic lung disease)

    📍 University of Alabama at Birmingham- Site Number : 8400003 · Birmingham, AL · +39 more US sites · Get directions →

    This is a parallel, Phase 2b/Phase 3, 3-arm study to investigate the efficacy, safety, and tolerability of subcutaneous (SC) treatment with lunsekimig compared with placebo in adult participants (aged 40 to 80 years, inclusive) with inadequately controlled Chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype. Participation to the study consists of 3 periods: * Screening period of up to 4 weeks * Randomized intervention period of approximately 48 weeks * Follow-up period: Approximately 8 weeks The study duration will be up to 60 weeks.

    ✓ Study care freePhase 3Ages 40–80Learn more →
  • Migraine / chronic headache

    Supraspinal Processing of Sensory Aspects of Pain

    Studying how the brain processes pain in children with migraine

    📍 Cincinnati Children's Hospital · Cincinnati, OH · Get directions →

    The goal of this basic science study is to learn about the brain mechanisms of chronic pain across different chronic pain syndromes in pediatric patients. The main questions it aims to answer are: * Are there shared and distinct brain systems engaged by different forms of pediatric chronic pain?

    ✓ Study care freeAges 10–17Learn more →
  • Fatty liver disease (NASH/MASH)

    📍 Arizona Liver Health · Chandler, AZ · +1 more US site · Get directions →

    This study is researching an experimental drug called ALN-CIDEB, also referred to as "study drug". The study is focused on participants with metabolic dysfunction-associated steatotic liver disease (MASLD) (Part A) and metabolic dysfunction-associated steatohepatitis (MASH) (Part B).

    ✓ Study care freePhase 1Ages 18–65Learn more →
  • Fatty liver disease (NASH/MASH)

    NAFLD Clinical Care Pathway

    Testing a care plan for people with non-alcoholic fatty liver disease

    📍 Michael E. DeBakey VA Medical Center, Houston, TX · Houston, TX · Get directions →

    Non-alcoholic fatty liver disease (NAFLD) is a new condition that has become the most common chronic liver disease in the world and a main cause of liver cirrhosis, liver failure and liver cancer. Obesity and diabetes, conditions that are very common among Veterans are the main risk factors for NAFLD.

    ✓ Study care freeAges 18+Learn more →
  • Fatty liver disease (NASH/MASH)

    A Research Study of a Potential New Medicine (NNC4005-0001) for Liver Disease in Adult Participants With Increased Body Weight and Liver Fat

    Testing a new medicine for liver disease in adults with extra body fat

    📍 Altasciences Clinical Company, Inc · Montreal, Quebec · Get directions →

    The purpose of this clinical study is to find out if NNC4005-0001 is well-tolerated and safe for people who have increased body weight and increased liver fat. Participants will receive either NNC4005-0001, which is the treatment being tested, or a placebo, which is a treatment that contains no active medicine.

    ✓ Study care freePhase 1Ages 18–69Learn more →
  • Heart / cardiovascular diseaseDepression

    AI Platform for Fatigue and Depression Detection

    Testing how well an AI tool can spot fatigue and depression in heart patients

    📍 Indiana University · Indianapolis, IN · +1 more US site · Get directions →

    This observational study evaluates the accuracy of the Okaya AI platform in detecting fatigue and depression in cardiology patients, comparing its assessments to PHQ-9 and Fatigue Assessment Scale scores.

    ✓ Study care freeAges 18–99Learn more →
  • Migraine / chronic headache

    RELAXaHEAD for Headache Patients (Phase III)

    Testing a remote program called RELAXaHEAD for people with migraine

    📍 NYU Langone Health · New York, NY · Get directions →

    This study is a fully powered, remote randomized control trial to evaluate RELAXaHEAD in people with migraine.

    ✓ Study care freeAges 16–80Learn more →
  • Fatty liver disease (NASH/MASH)

    A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

    Testing how efimosfermin alfa compares with placebo for MASH with scarred liver tissue

    💵 May compensate

    📍 GSK Investigational Site · Arcadia, CA · +39 more US sites · Get directions →

    The purpose of this study is to assess the safety and efficacy of efimosfermin alfa in the resolution of steatohepatitis and improvement of liver-related clinical outcome compared to placebo in individuals with MASH and biopsy-confirmed F2- or F3-stage fibrosis.

    ✓ Study care freePhase 3Ages 18–75Learn more →
  • Obesity / overweightHeart / cardiovascular disease

    The Weight of Cardiovascular Disease

    Testing how a heart and metabolism clinic affects weight loss in obese adults with heart disease

    📍 Mayo Clinic in Rochester · Rochester, MN · Get directions →

    The purpose of this study is to evaluate the impact of a cardiometabolic clinic on percent body weight loss, body mass index (BMI), and visceral adiposity distribution in obese adults with cardiovascular disease (CVD) at 12 months.

    ✓ Study care freeAges 18+Learn more →
  • Heart / cardiovascular diseaseKidney disease

    The Impact of Renal Transplant on Coronary Microvascular Function Among Patients With Advanced Chronic Kidney Disease

    Studying how kidney transplant affects tiny-heart-vessel blood flow in people with advanced chronic

    📍 Brigham and Women's Hospital · Boston, MA · Get directions →

    People with chronic kidney disease (CKD) often experience faster aging of the heart and blood vessels, which raises the risk of heart problems beyond traditional factors like high blood pressure or cholesterol. One early sign is reduced blood flow in the tiny vessels that supply the heart, measured by a positron emission tomography (PET) scan using a marker called myocardial flow reserve (MFR).

    ✓ Study care freeAges 18+Learn more →
  • Obesity / overweightHeart / cardiovascular disease

    Adapting and Testing a Novel Digital Health Tool (PREVENT) to Improve Health Behavior Counseling and Cardiovascular Health in Rural Primary Care Clinics

    Testing a digital health tool to improve weight and heart care talks in rural clinics

    📍 Washington University in St. Louis · St Louis, MO · Get directions →

    The focus on this application is low-income, rural patients, since cardiovascular disease (CVD) prevalence is 40% higher among rural than urban residents. Health behavior counseling and follow-up care are required for patients with an elevated body mass index who have increased risk for CVD.

    ✓ Study care freeAges 18–64Learn more →
  • COPD (chronic lung disease)

    A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

    Testing the long-term safety of astegolimab in people with COPD

    📍 UAB Lung Health Center · Birmingham, AL · +39 more US sites · Get directions →

    The purpose of this study is to assess the long-term safety and to explore the efficacy of astegolimab in participants with chronic obstructive pulmonary disease (COPD) who have completed the 52-week placebo-controlled treatment period in parent studies GB43311 or GB44332.

    ✓ Study care freePhase 3Ages 40–90Learn more →
  • High blood pressureCOPD (chronic lung disease)

    Phenotyping Resting and Exertional Right Ventricular Dysfunction Among Patients With Chronic Obstructive Pulmonary Disease

    Studying how the right side of the heart works at rest and during exercise in people with COPD

    📍 University of Colorado Anschutz Medical Campus · Aurora, CO · Get directions →

    This study plans to learn about heart function among individuals with chronic obstructive pulmonary disease (COPD). In particular, the investigators want to understand the different patterns of right ventricular response during rest and moderate- vs high-intensity exercise.

    ✓ Study care freeAges 40+Learn more →
  • Migraine / chronic headache

    A Study of Eptinezumab in Pediatric Participants With Episodic Migraine

    Testing whether eptinezumab lowers the number of days with episodic migraine in children

    📍 Ki Health Partners LLC DBA New England Institute for Clinical Research · Stamford, CT · +14 more US sites · Get directions →

    The main goal of this trial is to learn whether eptinezumab helps reduce the number of days with episodic migraine in pediatric participants.

    ✓ Study care freePhase 3Ages 6–17Learn more →
  • Obesity / overweightHeart / cardiovascular diseaseHigh blood pressure

    A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors

    Testing a new digital tool doctors can use to prescribe exercise

    📍 UConn Health · Farmington, CT · +2 more US sites · Get directions →

    The investigators will conduct a feasibility and pilot efficacy randomized controlled trial to test the usability and user satisfaction of an evidence-based digital health tool the investigators developed for physicians to use to Prioritize Personalize Prescribe EXercise (P3-EX) to patients with cardiovascular disease (CVD) risk factors. The investigators will recruit 24 physicians from two local hospitals in CT, USA.

    ✓ Study care freeAges 18–64Learn more →
  • Heart / cardiovascular diseaseKidney disease

    A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

    Testing whether orforglipron changes heart outcomes in adults with heart disease and/or kidney

    📍 Instituto de Investigaciones Clínicas Bahia Blanca · Bahía Blanca, · Get directions →

    The purpose of this study is to measure cardiovascular outcomes with orforglipron compared with placebo in participants with atherosclerotic cardiovascular disease (ASCVD) and/or chronic kidney disease (CKD). Participation in the study will last about 5 years.

    ✓ Study care freePhase 3Ages 50+Learn more →
  • Type 2 diabetesFatty liver disease (NASH/MASH)

    A Phase 1b Study of QX1206 in T2DM Patients With NAFLD

    Testing QX1206 in people with type 2 diabetes and fatty liver

    📍 Centricity Research Toronto LMC. · Toronto, · Get directions →

    This is an open label phase 1b trial of QX1206 in patients with T2DM and with NAFLD. Laboratory tests and other measurements will be assessed prior to the first dose of study treatment and throughout the study to determine the recommended phase 2 dose.

    ✓ Study care freePhase 1Ages 18–64Learn more →
  • COPD (chronic lung disease)

    A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

    Testing whether tezepelumab is safe and works for adults with COPD

    📍 Research Site · Foley, AL · +39 more US sites · Get directions →

    A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

    ✓ Study care freePhase 3Ages 40–80Learn more →
  • Migraine / chronic headache

    Efficacy of Xeomin for Migraines in Patients With Traumatic Brain Injuries vs. Anomalous Health Incidents

    Comparing Xeomin injections for migraine in people with TBI vs others

    📍 National Intrepid Center of Excellence (NICOE) · Bethesda, MD · Get directions →

    This cohort study aims to compare the efficacy of Xeomin injections for migraine management in patients with a history of Traumatic Brain Injury (TBI) versus those with a history of Anomalous Health Incidents (AHI). The study will be conducted at the National Intrepid Center of Excellence (NICOE) in Bethesda, MD.

    ✓ Study care freeAges 18+Learn more →
  • Fatty liver disease (NASH/MASH)

    Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis

    Testing a non-invasive ultrasound way to measure liver fat percentage

    📍 University of Washington · Seattle, WA · Get directions →

    The research study is considering a non-invasive way to measure the percentage of fat in the liver using ultrasound. This could help detect early signs of a very common condition called metabolic dysfunction-associated steatotic liver disease (MASLD).

    ✓ Study care freeAges 18–75Learn more →
  • Fatty liver disease (NASH/MASH)

    Androgens and NAFLD Longitudinal Cohort Study

    Studying how male-type sex hormones may affect NAFLD in young women over time

    📍 University of California San Francisco · San Francisco, CA · +1 more US site · Get directions →

    The researchers want to learn how androgens, a type of sex hormone, might affect nonalcoholic fatty liver (NAFLD) in young women over time. NAFLD happens when fat builds up in the liver which can cause damage to the liver such as inflammation or scarring.

    ✓ Study care freeAges 18–42WomenLearn more →
  • Fatty liver disease (NASH/MASH)

    📍 Arizona Liver Health · Chandler, AZ · +39 more US sites · Get directions →

    The primary objective of this trial is to evaluate the dose-dependent and comparative effects of ECC4703 (low and high dose), ECC0509 (low and high dose), and their combination on hepatic fat reduction as assessed by change in magnetic resonance imaging proton density fat fraction (MRI-PDFF) at Week 12.

    ✓ Study care freePhase 2Ages 18–75Learn more →
  • COPD (chronic lung disease)

    Pooled Analysis of Single-arm Studies of Budesonide/Glycopyrronium/Formoterol (BGF) in Routine Care Setting

    Analyzing how a COPD inhaler is used in routine care settings

    📍 Research Site · Mississauga, · Get directions →

    The CHOROS pooled analysis is a retrospective secondary data use analysis of integrated individual participant data from a series of planned and on-going primary prospective, non-interventional, multi-center studies sponsored by AstraZeneca and conducted in the pulmonary/primary care practitioner setting in multiple countries and may include data from the following countries: United Kingdom, Germany, Italy, Greece, Japan, Canada and Romania.

    ✓ Study care freeAges 18+Learn more →
  • Migraine / chronic headache

    BE WELL With Migraine: Brain Education and WELLness With Migraine

    Testing two different online non-drug programs for people with migraine

    📍 Cambridge Health Alliance - Center for Mindfulness and Compassion · Cambridge, MA · +2 more US sites · Get directions →

    The goal of this randomized clinical trial is to evaluate two different non-drug, virtual treatment options designed to improve the lives of patients with migraine. Both interventions involve 8 weekly sessions and an online platform with additional content and learning.

    ✓ Study care freeAges 18+Learn more →
  • Migraine / chronic headache

    Rimegepant as Preemptive Treatment for Predictable Trigger-Induced Migraine in Adult Patients in the US

    Testing rimegepant taken before a known trigger to prevent predictable migraine

    📍 MedStar Health: Neurology at McLean · McLean, VA · Get directions →

    Single-center, open label, prospective study conducted at Medstar Georgetown Headache Center. Men and woman ≥ 18 years old that are diagnosed with migraine with or without aura for at least 1 year, who report a reliable migraine trigger.

    ✓ Study care freePhase 4Ages 18+Learn more →
  • Migraine / chronic headache

    Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects

    Testing rimegepant versus placebo as a migraine prevention in kids

    📍 The Belinga Clinic · Fort Smith, AR · +39 more US sites · Get directions →

    The purpose of this study is to compare the efficacy and safety of rimegepant to placebo as a preventative treatment for migraine in children and adolescents ≥ 6 to \<18 years with episodic migraine.

    ✓ Study care freePhase 3Ages 6–17Learn more →
  • Migraine / chronic headache

    Study to Assess the Real-World Effectiveness of Ubrogepant in Adult Participants When Treating During the Prodrome Phase of Migraine Attacks

    Testing how well an oral migraine medicine works during the early warning phase

    📍 Neurology and Pain Specialty Center /ID# 278508 · Aliso Viejo, CA · +2 more US sites · Get directions →

    Migraine is a neurological disease characterized by moderate or severe headaches, associated with nausea, vomiting, and/or sensitivity to light and sound. This study will assess changes in migraine attack severity for adult participants treating with oral ubrogepant across migraine attacks.

    ✓ Study care freeAges 18+Learn more →
  • Heart / cardiovascular diseaseDepressionAnxiety

    Improving Care and Mental Well-Being for Adults With Heart Failure

    Testing ways to improve mental well-being for adults with heart failure

    📍 Seaway Valley Community Health Centre (Cardiac Rehab Program) · Cornwall, Ontario · Get directions →

    Heart failure is a high-risk, chronic condition that impacts patients' mental health. Approximately 50% of heart failure patients experience comorbid mental health conditions, such as stress, depression and anxiety, which affect their day-to-day lives.

    ✓ Study care freeAges 40+Learn more →
  • COPD (chronic lung disease)Asthma

    The Effects of Positive Airway Pressure on the Mucolytic Effects of NAC (TEAM)

    Testing whether positive airway pressure helps a lung medicine (NAC) reach mucus plugs in asthma or

    📍 UCSF Airway Clinical Research Center · San Francisco, CA · Get directions →

    The goal of this clinical trial is to determine if positive pressure during inspiration will improve penetration of aerosolized N-Acetylcysteine (NAC) into airway mucus plugs in the lungs of patients with asthma or Chronic Obstructive Pulmonary Disease (COPD). The main questions it aims to answer are: * Does delivery of aerosolized NAC with positive inspiratory pressure have a greater effect on mucus plug burden in the lungs than delivery of NAC without positive pressure.

    ✓ Study care freePhase 4Ages 18–85Learn more →
  • Migraine / chronic headache

    Emgality for Migraine in Breastmilk

    Studying whether a migraine medicine gets into breast milk and affects babies

    📍 University of California, San Francisco · San Francisco, CA · Get directions →

    The goal of this project is to evaluate galcanezumab transfer into maternal breastmilk, and to evaluate infant (growth, development, constipation, colic, infections) and maternal (headache) outcomes for dyads in which the mother was treated with galcanezumab and to compare outcomes for infants who were or were not breastfed after maternal treatment. In this prospective observational study, the study team proposes to prospectively collect serial milk samples from 30 adult women who are treated with galcanezumab for migraine.

    ✓ Study care freeAges 18–45WomenLearn more →
  • COPD (chronic lung disease)

    Effectiveness of the WearME System for COPD Severity and Respiratory Function

    Testing whether the WearME system tracks COPD severity and breathing

    📍 Johns Hopkins · Baltimore, MD · +1 more US site · Get directions →

    This observational study evaluates the effectiveness of the WearME system in monitoring COPD severity and respiratory function by comparing its measurements to standard spirometry, capnography, and other clinical assessments in 128 COPD participants.

    ✓ Study care freeAges 21–100Learn more →
  • COPD (chronic lung disease)

    📍 GSK Investigational Site · Sheffield, AL · +39 more US sites · Get directions →

    Depemokimab is being developed as a treatment for individuals with moderate to severe COPD. The aim of this study is to assess the efficacy and safety of depemokimab compared as an add-on medicine in participants with uncontrolled moderate to severe COPD with type 2 inflammation.

    ✓ Study care freePhase 3Ages 40–80Learn more →
  • Obesity / overweightHeart / cardiovascular disease

    WatchWell: Simple and Practical Strategies to Reduce the Negative Health Impact of Sedentary Screen Time

    Testing home tools and wearable devices to reduce health harms from evening screen time in people

    📍 Arizona State University · Tempe, AZ · Get directions →

    The purpose of this study is to determine the feasibility, acceptability, efficacy, and participant adherence in using home-based technologies and wearable devices and simple, practical strategies to reduce the negative impact that evening screen time may have on your health.

    ✓ Study care freeAges 26+Learn more →
  • COPD (chronic lung disease)

    To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

    Testing two doses of a daily medicine versus placebo in people with COPD over 52 weeks

    📍 DM Clinical Research - Phoenix · Phoenix, AZ · +11 more US sites · Get directions →

    This is a Phase 2 study of the efficacy, safety, tolerability and pharmacokinetics of two doses of EXPD-101 in participants with COPD. Study participants will be randomized to receive either study drug or placebo administered once daily for 52 weeks.

    ✓ Study care freePhase 2Ages 40–85Learn more →
  • DepressionAnxietyMigraine / chronic headache

    External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy

    Studying how safe and helpful external nerve stimulation is for migraine in pregnant women

    📍 https://public.smart-trial.co/#/public/649d77f0e8f8d0fb993d0c61/6626f6a04f0a3c7dd0860e14/662726d84f0a3c7dd08aeaa0/signup?lang=en-us&enforceLanguage=true · Darien, CT · Get directions →

    This online registry aims to understand the potential benefits and safety of external trigeminal nerve stimulation for the treatment of migraine in pregnant women. Women do not need to use external trigeminal nerve stimulation or any other form of migraine treatment to participate in the registry.

    ✓ Study care freeAges 18–44WomenLearn more →
  • Migraine / chronic headache

    Acceptance and Commitment Therapy to Improve Disability in Chronic Migraine

    Testing whether Acceptance and Commitment Therapy helps adults with chronic migraine function better

    📍 Brigham and Women's / Faulkner Hospital · Boston, MA · Get directions →

    The goal of this clinical trial is to learn if the behavioral treatment called Acceptance and Commitment Therapy (ACT) works to improve disability in adults with chronic migraine. The main questions it aims to answer are: Does the use of ACT added to usual treatment improve scores on questionnaires designed to measure daily functioning and activity?

    ✓ Study care freeAges 18–65Learn more →
  • Migraine / chronic headache

    Cocoa Extract for Migraine Trial

    Testing whether people with episodic migraine can stick to high-dose cocoa extract

    📍 Brigham and Women's Hospital · Boston, MA · Get directions →

    The goal of this clinical trial is to assess the feasibility of recruitment and adherence to a high-dose cocoa extract supplement in individuals diagnosed with episodic migraine. The main questions it aims to answer are: * Will we be able to enroll 114 participants during the recruitment period?

    ✓ Study care freeAges 18+Learn more →
  • COPD (chronic lung disease)

    The ROAM Research Study Therapy (LTOT) Version

    Testing a device that tracks how people with COPD use oxygen over time

    📍 University of Virginia · Charlottesville, VA · Get directions →

    The purpose of this research is to test a device being developed that can see how patients use oxygen therapy over a long period of time. This study will focus on developing a new display part called ROAM module which will be attached to your oxygen source.

    ✓ Study care freeLearn more →
  • Migraine / chronic headache

    A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

    Testing an oral medicine to track side effects and migraine changes in teens aged 12 to 17

    📍 Rehabilitation and Neurological Services /ID# 270782 · Huntsville, AL · +30 more US sites · Get directions →

    Migraine is a disease that most often causes moderate to severe headache on one side of the head. A migraine attack is a headache that may be accompanied by throbbing, nausea, vomiting, sensitivity to light and sound, or other symptoms.

    ✓ Study care freePhase 3Ages 12–17Learn more →
  • Type 2 diabetesHeart / cardiovascular disease

    Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes

    Testing how drinking ketone drinks affects heart function in people with type 2 diabetes and heart

    📍 University of Texas Health Science Center at San Antonio · San Antonio, TX · Get directions →

    This study will provide insight into whether cardiac function changes with oral Ketone Esters (KE) administered to patients with Type 2 Diabetes Mellitus (T2DM) and Heart failure with reduced ejection fraction (HFrEF). Plasma ketones are avidly extracted by cardiac muscle and their uptake is not dependent upon insulin or influenced by insulin resistance.

    ✓ Study care freeEarly Phase 1Ages 18–80Learn more →
  • COPD (chronic lung disease)

    Emphysema Research Registry and Biosample Repository

    Building a registry and sample collection to study emphysema and COPD

    📍 University of Pittsburgh Emphysema/COPD Research Center · Pittsburgh, PA · Get directions →

    The Comprehensive Lung Center (CLC) at the University of Pittsburgh Medical Center (UPMC Health System) provides patients with any type of breathing or lung disorder a full range of diagnostic and therapeutic services. The Emphysema/COPD Research Center (ECRC) is a specialty clinic, within this center, that attempts to advance the understanding of emphysema and to evaluate new therapies for patients with emphysema.

    ✓ Study care freeAges 21+Learn more →
  • Fatty liver disease (NASH/MASH)

    Impact of Soymilk on Liver Disease Severity of Children With Non-alcoholic Fatty Liver Disease (NAFLD)

    Testing whether daily soy milk affects liver disease in children with fatty liver

    📍 Cincinnati Children's Hospital Medical Center · Cincinnati, OH · Get directions →

    A randomized, controlled study of standard soy milk consumption compared to 2% fat cow's milk consumption in children with Non-alcoholic Fatty Liver Disease (NAFLD). The investigators hypothesize that the daily consumption of soy isoflavones found in the soy milk will be beneficial in reducing NAFLD and other obesity-related comorbidities.

    ✓ Study care freePhase 2Ages 5–12Learn more →
  • Obesity / overweightHeart / cardiovascular disease

    New Heart Imaging Techniques to Evaluate Possible Heart Disease

    Testing new heart imaging to check for possible heart disease

    💵 May compensate

    📍 National Institutes of Health Clinical Center · Bethesda, MD · Get directions →

    Background: \- Imaging tests, such as magnetic resonance imaging (MRI), can provide information about heart and blood vessels. The tests let doctors can see the amount of blood vessel narrowing and vessel wall thickness.

    ✓ Study care freeAges 18–100Learn more →
  • Migraine / chronic headache

    Investigating Brain Function in People With and Without Visual Snow Syndrome Using Adaptation to Visual Stimuli

    Studying how brain activity changes with visual images in people with visual snow syndrome or

    📍 University of Minnesota · Minneapolis, MN · Get directions →

    The goal of this study is to learn more about the brain pathways and activity involved in creating Visual Snow Syndrome (VSS). The main questions it aims to answer are: * Does VSS arise from spontaneous activity in brain pathways?

    ✓ Study care freeAges 18–60Learn more →
  • Obesity / overweightFatty liver disease (NASH/MASH)

    Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial

    Testing an endoscopic stomach procedure for people with obesity and MASH

    📍 Brigham and Women's Hospital · Boston, MA · +1 more US site · Get directions →

    Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most common chronic liver disease globally. While weight loss through lifestyle modification is the standard treatment, most patients regain weight limiting ultimate improvement in liver disease.

    ✓ Study care freeAges 18+Learn more →
  • Migraine / chronic headache

    Aimovig Pregnancy Exposure Registry

    Tracking birth defects in babies of pregnant women with migraine who take Aimovig

    📍 IQVIA Virtual Site · Durham, NC · Get directions →

    The primary objective of this study is to estimate the proportion of major congenital malformations in infants of women with migraine exposed to erenumab-aooe during pregnancy compared to infants of women with migraine unexposed to erenumeb-aooe.

    ✓ Study care freeAges 18–99WomenLearn more →
  • COPD (chronic lung disease)

    Photon-counting CT in Chest Imaging

    Testing photon-counting CT scans to measure lung damage in COPD

    📍 Duke University Hospital · Durham, NC · Get directions →

    Purpose and objective: This project aims to evaluate photon-counting computed tomography (PCCT) quantitative accuracy using COPDGene subjects. The goal is to establish acquisition protocols for PCCT scans with proper post-processing (e.g., reconstruction parameters and harmonization techniques) that enable reproducible measurements of emphysema metrics (e.g., Perc15, LAA-950, HU accuracy) and airways (Pi10, WA%) in the lungs.

    ✓ Study care freeLearn more →
  • COPD (chronic lung disease)

    COPD Patient-Powered Research Network

    Building a patient registry for people with COPD to share health info for research

    📍 COPD Foundation · Washington D.C., DC · Get directions →

    The COPD Patient-Powered Research Network (COPD PPRN) is a patient research registry with the goal of enrolling 75,000 or more COPD patients and those at risk who are willing to share their heath information over several years and participate in research. The COPD PPRN has built an online platform to allow volunteers to enroll electronically, complete surveys, be contacted about studies they qualify for and become connected to COPD resources.

    ✓ Study care freeAges 18+Learn more →
  • Migraine / chronic headache

    A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine

    Testing rimegepant tablets in adolescents with frequent migraine

    📍 Xenoscience Inc · Phoenix, AZ · +26 more US sites · Get directions →

    The purpose of this study is to learn about the effect of a study medicine called rimegepant in adolescents who have frequent migraine attacks. Rimegepant is a tablet that dissolves when you put it on or under your tongue.

    ✓ Study care freePhase 3Ages 12–17Learn more →
  • Migraine / chronic headache

    Endometriosis and Migraine

    Comparing pain and sex hormone levels in people with migraine and/or endometriosis

    📍 Washington University School of Medicine · St Louis, MO · Get directions →

    This study aims to determine differences in experimental pain and sex hormone levels between patients with migraine, patients with endometriosis, patients with migraine and endometriosis, and healthy controls. Participants will complete surveys, experimental pain paradigms and collection of samples for hormone analyses.

    ✓ Study care freeAges 12–45WomenLearn more →
  • Fatty liver disease (NASH/MASH)

    A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

    Testing a drug to treat fat buildup liver disease in people with stage 2 or 3 fibrosis

    📍 Akero Clinical Study Site · Birmingham, AL · +39 more US sites · Get directions →

    This is a multi-center evaluation of efruxifermin (EFX) in a randomized, double-blind, placebo-controlled study in subjects with non-cirrhotic NASH/MASH and fibrosis stage 2 or 3 (F2 or F3). The study will enroll subjects in two cohorts for a total samples size of 1650 subjects.

    ✓ Study care freePhase 3Ages 18–80Learn more →
  • COPD (chronic lung disease)

    Validation of Chronic Obstructive Pulmonary Disease (COPD) Algorithm

    Testing an algorithm to find chronic obstructive pulmonary disease (COPD) sooner

    📍 Wake Forest University Health Sciences · Winston-Salem, NC · Get directions →

    Under-diagnosis of Chronic Obstructive Pulmonary Disease (COPD) is prevalent, with an estimated 75% of adults suffering from COPD in the US, without clinical recognition. Often, the first diagnosis of COPD comes with a flare or exacerbation.

    ✓ Study care freeAges 40+Learn more →
  • Showing the first 60 of 358. Add filters or a location to narrow down.